Newron Pharmaceuticals S.p.A. current ratio

The Current Ratio as of November 2026 (TTM) for Newron Pharmaceuticals S.p.A. (NWPHF) is 3.15

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Current Ratio is 3.15. This represents a change of 57.24% compared to the average of 2.01 of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWPHF) Historical Current Ratio (quarterly & annually)

How has NWPHF Current Ratio performed in the past?

The mean historical Current Ratio of Newron Pharmaceuticals S.p.A. over the last ten years is 7.14. The current 3.15 Current Ratio has changed -55.83% with respect to the historical average. Over the past ten years (40 quarters), NWPHF's Current Ratio was at its highest in in the June 2018 quarter at 18.61. The Current Ratio was at its lowest in in the June 2007 quarter at 0.

Newron Pharmaceuticals S.p.A. (NWPHF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newron Pharmaceuticals S.p.A. (NWPHF) Average Current Ratio

How has NWPHF Current Ratio performed in the past?

The current Current Ratio of Newron Pharmaceuticals S.p.A. (NWPHF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Newron Pharmaceuticals S.p.A. (NWPHF) Current Ratio vs. Peers

How is NWPHF’s Current Ratio compared to its peers?

Newron Pharmaceuticals S.p.A.’s Current Ratio is greater than Faron Pharmaceuticals Oy (2.40), greater than AnGes, Inc. (0.95), greater than Hamilton Thorne Ltd. (2.04), less than Opsens Inc. (4.42), greater than Recce Pharmaceuticals Ltd (0.44), greater than Adocia S.A. (0.88), less than Dialogue Health Technologies Inc. (4.14), less than NIOX Group Plc (4.60), greater than Planet 13 Holdings Inc. (1.80), greater than Guerbet S.A. (0.96),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.